Clinical Trial Update: Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis [Phase 1]

View source ↗

Summary

Phase 1 study of intraperitoneal Triferic in patients on chronic peritoneal dialysis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Peritoneal Dialysis-related Anemia

Drugs mentioned

• Triferic (ferric pyrophosphate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: Peritoneal Dialysis (PD), Anemia | Phase 1 | Status: COMPLETED | Results posted: 2019-08-08